FMC is taking a hit for high channel inventories.
FMC Corporation has experienced a severe equity decline due to excessive debt and cyclical industry headwinds, but aggressive deleveraging is underway. Management is raising $1 billion to reduce net debt, likely lowering annual interest expense by roughly $70 million and improving tangible book value. A grain market recovery and bullish technical momentum suggest potential for a strong turnaround, with cash EPS possibly exceeding $2 in 2027.
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
Investors need to pay close attention to DAKT stock based on the movements in the options market lately.
Evaluate FMC's (FMC) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
While the top- and bottom-line numbers for FMC (FMC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FMC NYSE: FMC reported second-quarter revenue of $841 million excluding India, below the low end of its guidance range, as cautious customer purchasing, unfavorable weather, low insect pressure and pricing pressure weighed on demand. However, adjusted EBITDA of $153 million exceeded the high end of management's guidance by 2%, aided by cost discipline and favorable quarter-specific items.
FMC Corporation (FMC) Q2 2026 Earnings Call Transcript
FMC's Q2 earnings beat estimates as cost gains offset weaker pricing and volumes. Revenues declined and 2026 sales guidance was cut.
FMC (FMC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.69 per share a year ago.
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.